Search results for: Precision Medicine
Filter search results
Pharmacogenomics Testing: A Crucial Piece to Unlocking the Full Value of Medicines
5 June 2025
…Innovate UK, with OHE among the collaborators. Share this: Do Medicines Always Work as Intended? An estimated 70% of the UK population have received prescription medication. However, a substantial proportion of these medicines…
A Critique of Hill et al. (2018) on Estimated Costs of Production for the WHO Essential Medicines List
19 May 2018
…reviews “Estimated costs of production and potential prices of medicines for the World Health Organization Essential Medicines List” (Hill et al., 2018) in which the authors argue for “greater transparency…
Operationalising Value Based Pricing of Medicines: A Taxonomy of Approaches
1 August 2011
…prices for new medicines. From January 2014, the existing Pharmaceutical Pricing Regulation Scheme (PPRS) will be replaced by “value based pricing” (VBP) for branded medicines sold to the NHS. This…
OHE at ISPOR Philadelphia: Presentations and Posters
4 June 2015
…large prevalence diseases? Lessons from hepatitis C – Adrian Towse’s slides Early access to medicines: What is in it for payers? – Adrian Towse’s slides An Analysis of NICE ‘Recommended…
OHE at ISPOR Philadelphia Part 2: Risk Sharing, Medical Breakthroughs, Early Access and Drug Development Costs
12 May 2015
… Moderator: Dana Goldman (University of Southern California). Panelists: Adrian Towse (OHE), Ross Maclean (Precision Health Economics), Thomas Philipson (University of Chicago). This panel will discuss how the financial…
OHE’s AMR consultation response
21 November 2023
Why we need a new system for antibiotics Antibiotics, a sub-group of all antimicrobials, are fundamental for modern medicine. Antimicrobial resistance (AMR) is characterised by bacteria developing resistance to existing…
OHE at ISPOR Europe 2: Conceptual and Practical Challenges in Judging Value
29 October 2014
…Husereau, University of Ottawa and UMIT, Joshua J. Carlson (VeriTech Corporation) (IP6, 11 Nov, 10:15–11:15) This panel addresses the implications of assessing the cost-effectiveness of emerging regenerative medicines, including gene…
Valuing Co-Dependent Medical Technologies: Improving Methods and Processes
23 April 2013
…(2012) Can and should value based pricing be applied to molecular diagnostics? Personalized Medicine. 10(1), 61-72. An earlier version of this paper is available as an OHE Research Paper. …
Recommendations for Making Outcome-based Payments a Reality in the NHS: An Application to Cancer Drugs
21 February 2019
…for Future Health Technology Assessments in Oncology. OHE Consulting Report. RePEc. Towse, A. and Garrison, L., 2017. Value assessment in precision cancer medicine. Journal of Cancer Policy, 11, pp.48–53. DOI….